These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The pathologist's role in familial nonmedullary thyroid tumors. Cameselle-Teijeiro J Int J Surg Pathol; 2010 Jun; 18(3 Suppl):194S-200S. PubMed ID: 20484290 [No Abstract] [Full Text] [Related]
25. Thyroid tumors with follicular architecture. Turk AT; Wenig BM Ann Diagn Pathol; 2019 Feb; 38():51-58. PubMed ID: 30419427 [TBL] [Abstract][Full Text] [Related]
26. Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Sun D; Han S; Liu C; Zhou R; Sun W; Zhang Z; Qu J Med Sci Monit; 2016 Apr; 22():1210-7. PubMed ID: 27062921 [TBL] [Abstract][Full Text] [Related]
27. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma. Penna GC; Pestana A; Cameselle JM; Momesso D; de Andrade FA; Vidal APA; Araujo Junior ML; Melo M; Fernandes PV; Corbo R; Vaisman M; Sobrinho-Simões M; Soares P; Vaisman F Endocrine; 2018 Sep; 61(3):489-498. PubMed ID: 29948935 [TBL] [Abstract][Full Text] [Related]
28. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Takami H; Ozaki O; Ito K Arch Surg; 1996 Jun; 131(6):676. PubMed ID: 8645080 [No Abstract] [Full Text] [Related]
29. Role of miR-155-5p expression and its involvement in apoptosis-related factors in thyroid follicular carcinoma. Geng X; Sun YY; Fu JJ; Cao L; Li Y J Clin Pharm Ther; 2020 Aug; 45(4):660-665. PubMed ID: 32415722 [TBL] [Abstract][Full Text] [Related]
32. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures. Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706 [TBL] [Abstract][Full Text] [Related]
33. Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens. Giordano TJ; Beaudenon-Huibregtse S; Shinde R; Langfield L; Vinco M; Laosinchai-Wolf W; Labourier E Hum Pathol; 2014 Jul; 45(7):1339-47. PubMed ID: 24830619 [TBL] [Abstract][Full Text] [Related]
34. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker. Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747 [TBL] [Abstract][Full Text] [Related]
35. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Pallante P; Visone R; Croce CM; Fusco A Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715 [TBL] [Abstract][Full Text] [Related]
36. [Anatomo-pathology and histological prognosis of follicular thyroid carcinoma]. de Micco C Ann Endocrinol (Paris); 1997; 58(3):172-82. PubMed ID: 9239238 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany. Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986 [TBL] [Abstract][Full Text] [Related]